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Abstract
Background: Definitive endoderm (DE) gives rise to the respiratory apparatus and digestive tract. Sox17 and Cxcr4
are useful markers of the DE. Previously, we identified a novel DE marker, Decay accelerating factor 1(Daf1/CD55),
by identifying DE specific genes from the expression profile of DE derived from mouse embryonic stem cells (ESCs)
by microarray analysis, and in situ hybridization of early embryos. Daf1 is expressed in a subpopulation of
E-cadherin + Cxcr4+ DE cells. The characteristics of the Daf1-expressing cells during DE differentiation has not
been examined.
Results: In this report, we utilized the ESC differentiation system to examine the characteristics of Daf1-expressing DE
cells. We found that Daf1 expression could discriminate late DE from early DE. Early DE cells are Daf1-negative (DE-) and
late DE cells are Daf1-positive (DE+). We also found that Daf1+ late DE cells show low proliferative and low cell matrix
adhesive characteristics. Furthermore, the purified SOX17low early DE cells gave rise to Daf1+ Sox17high late DE cells.
Conclusion: Daf1-expressing late definitive endoderm proliferates slowly and show low adhesive capacity.
Keywords: Pluripotent stem cell, Definitive endoderm, Daf1, In vitro differentiation, Proliferation, Adhesion
Background
The definitive endoderm (DE) gives rise to the gastro-
intestinal and digestive system. In the mouse embryo,
the DE progenitors reside at the posterior region of the
epiblast that derived from the inner cell mass [1]. During
gastrulation, as the cells ingress through the primitive
streak, the epiblast segregates into the three germ layers
that form the somatic cell lineages of the ectoderm,
mesoderm, and definitive endoderm (DE). DE arises from
the Forkhead box A2 (Foxa2)-expressing anterior primitive
streak (APS) [2–5] and is then regionalized into the
fore-, mid-, and hindgut [6].
The DE is identified by the expression of SRY (sex-de-
termining region Y)-box 17 (Sox17) [7–9] and chemokine
(C-X-C motif ) receptor 4 (Cxcr4) [10–12]. Sox17 mutant
mouse embryos have a reduced DE, apoptosis of the
foregut, and abnormal morphogenesis of the mid- and
hindgut [9]. Sox17 is also required for the assembly of
the basement membrane, as the Sox17 mutant embryo
fails to segregate the DE from the mesoderm [13]. Activin
is a frequently used inducer for DE differentiation from
pluripotent stem cells, embryonic stem cells (ESCs), and
induced pluripotent stem cells (iPSCs) [14–16]. When
SOX17 is overexpressed, human ESCs spontaneously
differentiate into the DE, independent of Activin [17].
In zebrafish embryos, cxcr4a regulates directional migration
[11, 18] and DE proliferation during gastrulation [19]. In
chick embryos, Cxcr4 is expressed in the DE and angio-
blasts. Cxcr4 and its ligand Cxcl12 form a reciprocal signal-
ing loop that triggers angioblast migration to the pancreatic
endoderm and induces pancreatic development. Inhibition
of Cxcr4 suppresses angioblast migration into the pancre-
atic endoderm region. As a result, the size of the pancreas
decreases [10]. Although Cxcr4 is also expressed in the
mesodermal cells, it is often used in combination with
E-cadherin for purifying ESC-derived DE cells using
flow cytometry [12].
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Daf1 is an inhibitor of complementary activation [20].
Daf1 is expressed by immune cells and DE-derived tis-
sue, such as intestine and airway [21]. Using microarray
analysis and in situ hybridization, we previously identified
Daf1 as a DE cell surface marker based on its expression in
ESC-derived and embryonic DE. Daf1 is also expressed in
pancreatic progenitor cells [22, 23]. However, the role of
Daf1 in the DE is not well understood. In this study, we
found that the DE population that expresses Daf1 (Daf1 +
DE) has slow cell cycling and low cell-matrix adhesive char-
acteristics. Furthermore, Daf1-negative DE cells (Daf1-DE)
turn out to be Foxa2 + Sox17low cells and Daf1-positive DE
(Daf1 +DE) cells to be Foxa2 + SOX17high cells. Our results
therefore suggest that E-cadherin + Cxcr4 +DE is com-
posed of two populations: Sox17low early DE and Sox17high
late DE. Sox17high late DE cells were positive for Daf1, and
were slow proliferative and low cell-matrix adhesive cells.
Results
Daf1 + DE are slowly proliferating cells
Previously, we reported Daf1 as a surface marker, expressed
in a subpopulation of DE [23]. DE are defined as E-
cadherin+/Cxcr4+ cells [12]. When cultured in Activin-
containing medium [24, 25], ESCs sequentially give rise to
APS cells on day4 (defined as E-cadherin+/Pdgfra + cells),
then to DE cells (defined as E-cadherin+/Cxcr4+ cells) on
day 5 (Fig. 1). A plot of our previous microarray analysis re-
sults of the APS and DE cells [23, 24] shows the time
dependent expression of Foxa2, Sox17 and Daf1 (Fig. 1a).
Foxa2 was highly expressed in the APS and DE. Sox17 was
lowly expressed in the APS and highly expressed in the DE.
Daf1 expression was absent in the APS and present in
the DE (Fig. 1a). We then analyzed Daf1+ cells for the
expression of Nanog, a pluripotent marker, using a
mouse Nanog-iPS cell line bearing a green fluorescent
protein (GFP) reporter driven under Nanog promoter.
Daf1-positive cells turned out to be Nanog/GFP nega-
tive (Additional file 1). Taken together, Daf1 marks a
subpopulation of DE and is first expressed in the DE,
but not earlier in the APS.
To identify the differences between Daf1 + DE and
Daf1-DE cells, we purified Daf1+/-DE cells and compared
their properties. Real time PCR analysis of the sorted
Daf1+/-DE cells confirmed Daf1 expression is enriched
in Daf1 + DE (Fig. 1b, c). Expressions of an M phase
marker, phosphorylated histone H3 (pH3) or Proliferating
Cell Nuclear Antigen (PCNA) that marks proliferating
cells at every phase of the cell except G0 were enriched in
Daf1-DE than in Daf1 + DE cells, revealed by western blot
analysis (Fig. 1d). We analyzed the cell cycle phases and
found that Daf1 +DE cells showed a longer Go/G1 phase
and shorter S, M/G2 phase compared to Daf1-DE cells
(Fig. 1e, Additional file 2). This suggested that cell prolifer-
ation was decreased in Daf1 + DE.
Daf1 + DE are low adhesive cells
Next, we performed flow cytometry using antibody against
Daf1and plated at a same cell number of the sorted DE
cells (Daf1-DE or Daf1 + DE) onto matrigel-pre-coated
dishes (Fig. 2a). After 24 h culture, the Daf1+ DE gave rise
to fewer cell number compared to that of Daf1-DE (Fig. 2b,
c). The results suggested a higher level of cell death and/
or lower plating efficiency of Daf1 +DE cells. We then ex-
amined cell-matrix adhesion and the extent of apoptosis,
in which cells were allowed to adhere to the plate for 90
mins [26, 27] [28]. Our results revealed that Daf1 +DE
cells showed a lower matrix adhesion ratio than Daf1-DE
(Fig. 2d), and that Daf1 + DE cells were more apoptotic
and showed a higher Cleaved Caspase3/7+ ratio (Fig. 2e)
than Daf1-DE. Cells bind to extracellular matrix (ECM)
through the ECM receptor, integrin [29, 30]. We found
that expression of several subtypes of the Integrin genes,
such as Itgα1, Itgα3, and Itgα8, was down-regulated in
Daf1 + DE cells (Fig. 2f). Our results suggest that Daf1 +
DE cells have lower adhesion capacity than Daf1-DE cells,
which led to a lower plating efficiency and triggered cell
death in the attached cells, compared to Daf1-DE cells.
Daf1 is a marker of late stage DE
To characterize the adherent cells onto Matrigel- pre-
coated dish, we assayed for the expression of the DE
markers, Foxa2 and Sox17, immediately after the adhesion
assay (Fig. 3). Interestingly, whereas both Daf1+/-DE pop-
ulations showed similar capacity for giving rise to Foxa2-
expressing cells, Daf1 + DE cells showed a higher capacity
for giving rise to Sox17-expressing cells (Fig. 3a, b). Foxa2
is expressed in both the APS and DE, whereas Sox17 is
expressed at a higher level in the DE. We then confirmed
Sox17 protein expression of the sorted Daf1+/-DE cells
directly (without plating) by immunocytochemical analysis
(Fig. 3c). Sox17 expression was found in a higher propor-
tion and seemingly higher level in the sorted Daf1 + DE
cells compared to Daf1-DE cells (Fig. 3c). Western blot
analysis confirmed a higher level of Sox17 expression in
the Daf1 + DE cells (Fig. 3d). Since Foxa2 expression is de-
tected prior to that of Sox17, we then asked if Daf1-DE
cells represent early DE and Daf1 + DE cells represent
late DE, by examining if Daf1-DE cells differentiate into
Daf1 + DE. Daf1+/-DE cells sorted by flow cytometry
(purity >97.8 %, Daf1 and Cxcr4 expression profiles
shown in Fig. 3e) were re-cultured on mouse embry-
onic fibroblast (MEF) feeders with Activin containing
endoderm differentiation medium. We examined the
expression of Daf1. To exclude MEF feeders, we ana-
lyzed E-cadherin + cells. Almost all of the Daf1-DE cells
acquired Daf1 expression over the course of 24 h and
gave rise to Daf1 +DE (>96.7 %), whereas Daf1 +DE cells
did not turn into Daf1-DE (Fig. 3e). Taken together, these
results suggest that Daf1-DE represent early and Daf1 +DE
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represent late DE cells during DE differentiation and that
Daf1-DE become Daf1 +DE cells (Fig. 3f).
Daf1+/-DE cells can give rise to pancreatic and intestinal fates
We identified that Daf1-DE cells acquired Daf1 expres-
sion and turned into Daf1 + DE. If Daf1-DE represents
early DE and Daf1 +DE represents late DE, both DE cells
could give rise to regional endoderm derivatives of the
gut. We next examined the abilities of the Daf1+/-DE cells
to differentiate into pancreatic or intestinal cells. To
visualize pancreatic differentiation, we used Pdx1/GFP
mouse ESCs, in which GFP expression is driven by the
Fig. 1 Daf1+ DE cells are less proliferative than Daf1- DE cells. a Mouse ESCs (ESC) were differentiated first to the anterior primitive streak then into the
definitive endoderm (DE). Our previously reported microarray analysis of Foxa2, Sox17 and Daf1 expression during DE differentiation are plotted in a
time dependent manner. Daf1 expression increased in the DE but not in the APS. ESC; mouse embryonic stem cells, APS; anterior primitive streak, DE;
definitive endoderm. b Schematic drawing of the experiment to analyze cell cycle phases of the sorted DE. ES cells were differentiated into DE, then
dissociated and sorted for Daf1+/- cells. The sorted cells were immediately analyzed for cell cycle. c Real time-PCR analysis showed that Daf1 expression
was enriched in Daf1+ DE. Y axis shows relative gene expression, with 1 equivalent to Daf1 expression level in Daf1 + DE cells. d, e Proliferative
properties of Daf1 + DE and Daf1-DE cells were assayed. d Cell proliferation marker, pH3 (M phase), and PCNA (every cell phases except G0)
was down-regulated in Daf1 + DE. Analyzed by western blot analysis. e Cell cycle analysis revealed that Daf1 + DE reside longer in the G0/G1 phase
with a shorter S and M/G2 phases compared to that of the Daf1-DE cells. Raw data are shown in Additional file 2. Student’s two tailed t-test
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Pdx1 promoter [25]. We isolated Daf1+/-DE cells by flow
cytometry (purity > 98 %), seeded the cells on MEF
feeders, and cultured in the presence of Activin and FGF2
(Fig. 4a) [25]. We found that both Daf1- DE and Daf1+
cells gave rise to Pdx1/GFP+ cells, after plated for 3 days
(day 8). The Daf1 + DE-derived cells yielded less Pdx1/
GFP cells compared to that of the Daf1-DE cells (Fig. 4b,
c). This discrepancy was probably due to a lower prolifera-
tion of the Daf1 + DE cells compared to Daf1-DE cells.
Since the pancreas derives from the anterior DE, we then
asked if the Daf1+/-DE cells could also differentiate into
the posterior DE derivative of the intestine. DE derived
from R1 ESCs were sorted and seeded onto MEF feeders
and cultured at the presence of BIO and DAPT [16, 31].
After five days, both Daf1-DE and Daf1 + DE cells
differentiated into Cdx2+ intestinal cells. Similar to pan-
creatic differentiation, Daf1 + DE cells are less proliferative
and gave rise to small Cdx2+ colonies than Daf1-DE
cells (Fig. 4c). Our results therefore suggest that both
Daf1+/- DEs are capable of differentiating into the
endodermal derivatives of the pancreas and intestine.
Discussion
Previously, we identified that Daf1 is expressed in the
DE. Here, we identified Daf1 as a late DE marker. Daf1
is an inhibitor of complement activation [20]. Daf1 is
expressed in the kidney, spleen, testis, intestine, and
bronchi of the adult mouse [21]. Daf1 deficiency is re-
ported in autoimmune hemolytic anemia patients [32].
In Daf1 knockout mice, IFN-γ expression increases,
Fig. 2 Daf1+ DE cells have lower cell-matrix adhesion than Daf1- DE cells. a A schematic drawing showing experimental design. The sorted DE
cells were plated onto matrigel-pre-coated dishes and cultured for 24 h (b, c) or 90 min (d, e). b Transmission images of the cells derived from
the Daf1+/-DE cells after cultured for 24 h. c After 24 h culture, the Daf1 + DE cells gave rise to fewer cells. d Cell-matrix adhesion assay, after
90 min culture. Quantification of the attached cells. The adhesion ability of Daf1 + DE cells onto matrigel is weaker than that of the Daf1-DE
cells. e Quantification of Cleaved caspase3/7+ apoptotic cells. The Daf1 + DE cells gave rise to a larger proportion of apoptotic cells. f The
Integrin expression profiles of the DE cells detected by RT-PCR analysis. Student’s two tailed t-test. Scale bars; 100 μm
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resulting in enhanced T cell response autoimmunity
[33]. However, gastrointestinal-tract develops normally
in Daf1 knockout mice. Here, we examined the detailed
expression patterns during DE differentiation using ESCs.
DE cells are defined as E-cadherin+/Cxcr4+ cells [12].
However, both E-cadherin and Cxcr4 are also expressed
in the primitive streak [34, 35]. Therefore, the use of
E-cadherin+/Cxcr4+ as a marker to define the DE cells
is confined to a limited time window. Moreover, E-
cadherin+/Cxcr4+ DE cells are a heterogeneous popula-
tion. Here we used Daf1 to characterize a subpopulation
of E-cadherin+/Cxcr4+ DE cells. We revealed that both
Daf1-DE cells represent early DE and Daf1 + DE represent
late DE. Daf1-DE and Daf1 +DE cells can give rise to the
pancreatic and intestinal lineages. Daf1 + DE formed small
colonies, due to their less proliferative and low adhesive
characteristics than that of Daf1-DE cells (Fig. 5). A slight
decrease in S, M/G2 phase and increase in G0/G1 phase
in Daf1 + DE cells might reflect their property as more dif-
ferentiated cells. Daf1 + DE cells seem to differentiate as
efficiently into Pdx1-expressing cells, but not as efficiently
into Cdx2-expressing cells, compared to Daf1-DE cells.
This might due to a partial loss in differentiation potency
of Daf1+ DE cells into the intestinal fate. We previously
reported that regional-specific endodermal fates are deter-
mined sequentially in the order of stomach, intestine and
pancreas, in the chick embryos [36]. It is possible that
Daf1 + DE gradually lose potency to differentiate into in-
testinal lineages, but retains differentiation potency into
pancreatic lineages, compared to that of Daf1-DE.
Fig. 3 Daf1-DE is the progenitor of Daf1+ DE. a A schematic drawing showing experimental design. b Quantifications of Foxa2+ and Sox17+ cells by
immunocytochemistry after 90 min cell-matrix adhesion assay. c, d The proportion of cells expressing Sox17 was higher in the Daf1 + DE as detected
by immunocytochemical analysis (c), and the level of Sox17 expression was higher in the Daf1 + DE as detected by western blot (d), of the sorted DE
cells (without plating). e Flow cytometry analysis of the descendent cells of Daf1-DE and Daf1 + DE. Left panels: Daf1, Cxcr4 expression profiles of the
sorted Daf1+/- DE cells. Right panels: both Daf1-DE and Daf1 + DE acquired Daf1 expression after 24 h. f The scheme of Fig. 3. Sox17low Daf1-DE
differentiated into Sox17high Daf1 + DE. Student’s two tailed t-test. Scale bar; 100 μm
Ogaki et al. BMC Developmental Biology  (2016) 16:19 Page 5 of 9
Cell-matrix adhesion is also necessary for cell differ-
entiation [37, 38]. Integrin expression promotes DE dif-
ferentiation from human pluripotent stem cells [39].
Integrin is a receptor of extracellular matrix expressed
in the cells, which enables binding of the cells to the
extracellular matrix. Itgα5 and ItgαV are DE-specific
Integrins. Knockdown of either Itgα5 or ItgαV inhibits
DE differentiation [39]. Both Daf1- and Daf1 + DE cells
express Itgα5 and ItgαV. We found that the expressions
of Itgα1, Itgα3, and Itgα8 decreased in Daf1 + DE cells.
Itgα1 is an attachment molecule of the DE [40]. Itgα3 is
expressed in the DE and expression decreases in the
Foxa2 null mouse embryo [41]. Itgα8 null mice have
abnormal lung morphogenesis [42]. These Daf1-DE
specific integrins could regulate DE differentiation and
modulate their behavior. The integrins are known to
show distinct ligand binding specificities among the
superfamily members. Itgα1β1, Itgα3β1 bind specifically
to laminin and Itgα8β1 binds specifically to fibronectin
[43]. The lowered expression of Itgα1, Itgα3 might ex-
plain the decreased adhesion of Daf1 + DE cells to
Matrigel, which composed mainly of laminin. The decrease
in adhesion to matrix might reflect the developmental
transition from early to late DE.
Fig. 4 Both Daf1+/- could differentiate into pancreatic and intestinal fates. a A schematic drawing showing experimental design. DE was sorted
on day 5. The sorted cells were plated onto MEF feeders and cultured with pancreatic and intestinal differentiation medium. Daf1- or Daf1 + DE
cells differentiated into Pdx1/GFP+ cells after 4 days culture (b) and Cdx2+ cells after 5 days culture (c). b Arrows depict small colonies of
Daf1 + DE-derived Pdx1/GFP+ cells. Numbers depict differentiation ratios: Daf1-DE-derived Pdx1/GFP+ cells; 10.9 %, Daf1 + DE-derived Pdx1/
GFP+ cells; 12 % (day 9). c Numbers depict differentiation ratios: Daf1-DE-derived Cdx2+ cells; 18.3 %, Daf1 + DE-derived Cdx2+ cells; 17.1 %
(day 10). Scale bar; 100 μm
Fig. 5 Proposed role of Daf1 in DE differentiation. ICM/ESC differentiated into the E-cadherin + Cxcr4 + Foxa2 + Sox17lowDaf1- early DE. These cells
then differentiated into the E-cadherin + Cxcr4 + Foxa2 + SOX17highDaf1+ late DE. The late DE differentiated into regionalized anterior (pancreatic)
and posterior (intestinal) endodermal lineages. Transition from the Daf1-DE to Daf1 + DE is accompanied by restricted cell proliferation and cell-matrix
adhesion. ICM; inner cell mass
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We found that Daf1-DE could turn into Daf1 + DE
cells. Sox17 expression was higher in Daf1 + DE than in
Daf1-DE cells. Furthermore, expression of a primitive
streak marker, Brachyury [44], was higher in Daf1-DE
cells (SO unpublished). Therefore, E-cadherin+/Cxcr4+
DE could be a mixed population of both primitive streak
and DE cells.
Conclusions
Our data indicate that DE can be divided into two stages:
early and late DEs. Early DE consists of E-cadherin +
Cxcr4 +Daf1-Foxa2 + Sox17low cells that show higher pro-
liferative activity and higher cell-matrix adhesive capacity.
Later on, these DE cells differentiate into E-cadherin +
Cxcr4 +Daf1+ Foxa2 + Sox17high late DE cells that show
a decreased proliferation and low cell-matrix adhesion
capacity.
Our findings would contribute to the understandings




ESC cell lines (R1, SK7 Pdx1/GFP) [25] or a mouse Nanog
iPS cell line (20D-17) [45], were maintained on a feeder
layer of mouse embryonic fibroblasts (MEFs) in Dulbec-
co’s Modified Eagle Medium (DMEM) (Invitrogen) sup-
plemented with human recombinant LIF (1:1000, Wako),
10 % fetal bovine serum (FBS, Hyclone), 2 mML-glutam-
ine (L-Gln, Nacalai Tesque), 100 mM non-essential amino
acids (NEAA, Invitrogen), 50 U/mL penicillin, 50 mg/ml
streptomycin (PS, Nacalai Tesque), and 100 μM 2-
mercaptoethanol (2-ME, Sigma-Aldrich) in 5 % CO2.
Differentiation of ESCs
DE differentiation: ESCs or iPSCs (104 cells/ml) were
seeded onto mitomycin C (Sigma)-treated M15 feeders,
and cultured in the presence of 10 ng/ml Activin (R&D
systems) in DMEM containing 10 % FBS, 2 mM L-Gln,
100 mM NEAA, PS, and 100 μM 2-ME. Pancreatic dif-
ferentiation: Sorted DE cells were seeded onto MEF
feeders and cultured with DE differentiation medium
supplemented with 5 ng/ml FGF2 (Peprotech). Intestinal
differentiation: Sorted DE cells were seeded onto MEF
feeders and cultured with DMEM (2000 mg/ml glucose)
and 5 μM bromoindirubin-3′-oxime (BIO) (Wako),
10 μMN-[(3, 5-diflurophenyl) acetyl]- L-alanyl-2-phenyl-
glycine-1, 1-dimethylethyl ester (DAPT) (Peptide), 10 %
Knockout Serum Replacement (KSR)(In vitrogen), 2 mM
L-Gln, 100 mM NEAA, PS, and 100 μM 2-ME.
Microarray analysis
Our previously described results were used in the
present study [22, 23].
Antibodies
For immunocytochemical analysis, goat anti-Sox17 anti-
body (1:100, R&D systems), rabbit anti-Hnf3b/Foxa2
(1:200, Millipore), mouse anti-Cdx2 (1:500, BioGenex)
and rabbit anti-GFP (1:1000, MBL) were used. For flow
cytometric analysis, rat anti-E-cadherin (1:500, TaKaRa),
biotin anti-Cxcr4 (1:500, BD Biosciences), PE anti-CD55/
Daf1 (1:100, BD Biosciences), PE/Cy7 Streptavidin (1:500,
Biolegend) antibodies were used. E-cadherin antibody was
labeled by Allophycocyanin Labelling Kit-SH2 (DOJINDO).
For Western blot analysis, mouse anti-α-tubulin (1:2000,
12G10, Developmental Studies Hybridoma Bank), mouse
anti-phospho-Histone H3 (Ser10) antibody (1:500, Milli-
pore), rabbit anti-Sox17 antibody (1:100, Sigma-Aldrich)
and mouse anti-PCNA (1:500, Oncogene, NA03-200UG)
were used.
Immunocytochemical analysis
Cells were fixed with 4 % paraformaldehyde (PFA) (Nacalai
Tesque) for 5 min. After fixation, cells were permeabilized
with 0.1 % TritonX (Nacalai Tesque) for 10 min. Then, cells
were blocked with Blocking One (Nacalai Tesque) and
stained with antibodies.
Flow cytometry analysis
Cells were dissociated with Cell Dissociation Buffer
(Invitrogen) and stained with the appropriate antibodies.
The stained cells were recovered using FACS Aria II (BD
Biosciences). Data were recorded using the BD FACS Diva
Software program (BD Biosciences) and analyzed using
the FlowJo program (Tree Star).
Western blot analysis
Cells were homogenized in SDS sample buffer (62.5 mM
Tris–HCl, 10 % glycerol, 2 % SDS, pH 6.8). After centri-
fugation, the supernatants were collected and used as
total protein extracts. Total proteins were subjected to
8 % SDS-PAGE and transferred to polyvinylidene difluoride
membranes (Immobilon-P Transfer Membrane, Millipore).
The membranes were incubated with antibodies listed
above. Horseradish peroxidase (HRP) conjugated anti-
rabbit IgG (1:20000, CST) was used as the secondary
antibody. Chemiluminescence signals were detected
with ECL Plus Western Blotting Detection Reagents
(GE Healthcare, Japan).
RT-PCR analysis
RNA was extracted from the cells using the RNeasy
Micro-Kit (QIAGEN) and then 1 μg of RNA was reverse
transcribed using ReverTra Ace (TOYOBO), ribonucle-
ase inhibitor, recombinant (TOYOBO), and Oligo dT
primers (TOYOBO). Primer sequences are shown in
Additional file 3.
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Cell cycle analysis
Cells were dissociated with Cell Dissociation Buffer (Gibco).
Dissociated cells were washed with PBS and treated with
Vybrant DyeCycle Violet Stain (Life Technologies) for
30 min at 37 °C. Cells were analyzed by FACS Canto (BD
Biosciences).
Cell- matrix adhesion analysis
The sorted cells were plated onto matrigel-precoated dishes
with serum free medium for 90 min. The attached cells
were fixed with 4 % PFA for 5 min, then stained with DAPI
(1:2000, Roche). Cell counts were performed as previously
described [46].
Apoptosis assay
For the apoptosis assay, caspase-3/7 activity was measured
using CellEvent™ Caspase-3/7 Green Detection Reagent
(Invitrogen Life Technologies Co., Carlsbad, CA, USA) ac-
cording to the manufacturer’s protocol.
Additional files
Additional file 1: Daf1-positive cells are negative for Nanog expression.
Mouse Nanog-iPS cells, in which GFP expression is driven by Nanog
promoter [45], are differentiated into DE. Cxcr4+/E-cadherin + cells were
sorted and analyzed for Daf1 and Nanog-GFP expression. Daf1-positive
cells are negative for Nanog expression. (TIF 312 kb)
Additional file 2: Flow cytometric analyses of the cell cycle. Histograms
of flow cytometric analyses of Daf1-DE and Daf1 + DE (n = 5) are shown.
Cell cycle was analyzed by measuring DNA quantities using DyeCycle.
(TIF 314 kb)
Additional file 3: Primer sequences used for RT-PCR analysis. Primer
sequences used for detection of gene expression in Fig. 1, 2. (DOCX 15 kb)
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